Company Chosen to Compete at Group’s Annual Holiday Dinner Following Lengthy Selection Process From 120 Applicants

 

SAN DIEGO, December 1, 2016 — Poïesis Therapeutics, a biotechnology start-up in the pet health industry, is pleased to announce that the company has been chosen as a finalist to compete in the San Diego Venture Group’s Annual VC PitchFest Holiday Dinner & Business Plan Competition to be held December 13th at the Hyatt Regency La Jolla at Aventine.

PitchFest is designed to showcase new start-up companies that have not raised more than $2.0M in capital and/or received $3.0M in grant funding and is open to companies in all fields throughout Southern California, with San Diego start-ups preferred.

“I am absolutely thrilled and honored to be able to present the Poïesis business model to the large audience of investors who will be attending this year’s PitchFest Holiday Dinner,” said Jessica Dugan, DVM, MBA, Co-Founder, President and CEO of Poïesis Therapeutics.”With the recent opening of our Seed Round of financing, this presentation will go a long way towards alerting the local investment community to the opportunity represented by Poïesis”

The selection of Poïesis comes after a two step process in which 30 judges first selected 12 semi-finalists — six from life sciences and six from tech/consumer — ­from over 120 company applications.

The CEOs of each of the semi-finalist companies then presented before separate panels of life science and tech/consumer experts who chose four companies as finalists — two from the life science group and two from the tech/consumer group.

Along with the CEOs of the three other finalist companies, Poïesis CEO Jessica Dugan will pitch to a dinner audience of more than 400 venture capitalists, angel investors and entrepreneurs, who will cast their votes to decide the winning companies — one in life sciences and one in tech/consumer. Companies will be competing for cash prizes of $25,000.

More information on the 2016 VC PitchFest Holiday Dinner can be found here. If you are local to San Diego please come show your support at the dinner – the audience votes for the winner!

About Poïesis Therapeutics
Poïesis Therapeutics Inc. is a biotechnology start-up in the pet health industry focused on sourcing and in-licensing late stage therapeutics and diagnostics from human biotechnology research and developing them to address unmet needs in companion animals — dogs, cats and horses.

About San Diego Venture Group
Founded in 1986, SDVG is a non-profit organization designed to bring together people who are interested in new ventures and furthering individual companies, as well as our overall innovation community. With about 800 individual and corporate members, the SDVG has as its primary mission the fostering relationships and ideas to form, fund, and build new ventures.